ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V.; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Period	TotalRevenue
2015-12-31	$6.13M
2016-12-31	$5.75M
2017-12-31	$7.38M
2018-12-31	$7.35M
2019-12-31	$11.22M
2020-12-31	$12.83M
2021-12-31	$16.30M
2022-12-31	$20.55M
2023-12-31	$23.95M
2024-12-31	$31.39M

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CLPT	$9.08	+0.11%	0.48M
3
4
5

ClearPoint Neuro, Inc. (CLPT) Revenue History

Revenue Data

Get ClearPoint Neuro, Inc. Data in Excel

More CLPT Financial Data